16 related articles for article (PubMed ID: 2495624)
1. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
Liu CP; Bach FH; Wu SK
J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
[TBL] [Abstract][Full Text] [Related]
2. Endogenous peptides contribute to the ligand recognized by anti-DR1 human alloreactive T cells.
Lombardi G; Sidhu S; Lamb JR; Batchelor JR; Lechler RI
Transplant Proc; 1989 Feb; 21(1 Pt 1):142-4. PubMed ID: 2495597
[No Abstract] [Full Text] [Related]
3. Unusual functional and biochemical properties of DR molecules from the HLA-DR1, B14 haplotype.
Davis JE; Cook RG; Brown MF; Pollack MS; Van M; Rich RR
Transplant Proc; 1987 Feb; 19(1 Pt 1):851-7. PubMed ID: 3493566
[No Abstract] [Full Text] [Related]
4. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
Long AB; Ferguson AM; Majumder P; Nagarajan UM; Boss JM
Mol Immunol; 2006 Feb; 43(5):395-409. PubMed ID: 16337482
[TBL] [Abstract][Full Text] [Related]
5. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
6. Reversal of an immune response gene effect by point mutation in the antigen sequence.
Lechler RI; Bal V; Ikeda H; Trowsdale J; Rothberd JB; Lamb JB
Transplant Proc; 1989 Feb; 21(1 Pt 1):618-20. PubMed ID: 2495624
[No Abstract] [Full Text] [Related]
7. Molecular organization of the class II genes of the human and mouse major histocompatibility complexes.
Carson S; Trowsdale J
Oxf Surv Eukaryot Genes; 1986; 3():63-94. PubMed ID: 2855304
[No Abstract] [Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
